(Q1592932)

Statements

instance of

type of chemical entity

0 references

subclass of

granulocyte colony-stimulating factor

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148730

retrieved

27 February 2018

granulocyte-macrophage colony-stimulating factor

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148730

retrieved

27 February 2018

has use

medication

1 reference

title

Pegfilgrastim (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00019

image of molecular model or crystal lattice model

Filgrastim.jpg
500 × 500; 52 KB

depicts

ribbon diagram

0 references

defined daily dose

0.3 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L03AA13

active ingredient in

Neulasta

1 reference

European Medicines Agency product number

EMEA/H/C/000420

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000420/human_med_000924.jsp

retrieved

22 March 2017

Neupopeg

1 reference

European Medicines Agency product number

EMEA/H/C/000422

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000422/human_med_000925.jsp

retrieved

22 March 2017

Ristempa

1 reference

European Medicines Agency product number

EMEA/H/C/003910

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003910/human_med_001859.jsp

retrieved

22 March 2017

World Health Organisation international non-proprietary name

pegfilgrastim (English)

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL1201568

language of work or name

English

title

Pegfilgrastim (English)

retrieved

19 January 2016

medical condition treated

neutropenia

2 references

stated in

NDF-RT

NDF-RT ID

N0000148730

language of work or name

English

retrieved

13 December 2016

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

colon cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

lung carcinoma in situ

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

diffuse large B-cell lymphoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

chronic lymphocytic leukemia

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

non-Hodgkin lymphoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

agranulocytosis

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

lymphoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

B-cell lymphoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

physically interacts with

Colony stimulating factor 3 receptor

subject has role

agonist

1 reference

stated in

Open Targets Platform

retrieved

14 August 2023

reference URL

https://platform.opentargets.org/drug/CHEMBL1201568

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

has characteristic

biopharmaceutical

1 reference

title

Pegfilgrastim (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00019

NCI Thesaurus ID

C1854

1 reference

stated in

Global Substance Registration System

UNII

3A58010674

retrieved

14 February 2018

Identifiers